HMGB2 and pancreatic ductal adenocarcinoma: Increasing evidence suggests that HMGB2 is involved in various malignancies like prostate cancer, cervical cancer, lung cancer, melanoma, pancreatic ductal adenocarcinoma (PDAC), and GC.